Biopharmaceutical and Biologics


Biologics are genetically engineered proteins derived from human genes. They are designed to inhibit particular components of the immune system that play pivotal roles in fuelling inflammation, which is a central feature of rheumatoid arthritis. The pathophysiologic rationale for, and clinical application of, Biologic agents in the management of autoimmune diseases, cancers, or other pathologies where a molecular target can be identified.



 


  • Nanobiopharmaceuitics
  • Medical devices
  • Biologics: sugars, proteins, nucleic acids

Related Conference of Biopharmaceutical and Biologics

May 05-06, 2025

19th World Drug Delivery Summit

Vancouver, Canada
June 16-17, 2025

3rd Global Online Summit on Nanoscience and Nanotechnology

Zurich, Switzerland
June 23-24, 2025

38th World Congress on Pharmacology

Paris, France
August 18-19, 2025

40th World Congress on Pharmacology and Therapeutics

Valencia, Spain
September 22-23, 2025

Pharma Biotech Expo

Toronto, Canada
September 23-24, 2025

10th International Conference on Future Pharma and Innovations

Amsterdam, Netherlands
November 20-21, 2025

21st Annual Congress on Pharmacology and Toxicology

Aix-en-Provence, France
November 27-28, 2025

4th World Congress on Precision and Personalized Medicine

Zurich, Switzerland
November 27-28, 2025

13th International Conference on Clinical Trials

Amsterdam, Netherlands
November 27-28, 2025

4th World Conference on Pharma Industry and Medical Devices

Zurich, Switzerland

Biopharmaceutical and Biologics Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in